2019-05-21 22:40:00| Fool.com Headlines
Tough conditions for these companies left them out of the day's rally.
2019-05-21 22:27:00| Fool.com Headlines
The clinical-stage developer of RNAi therapies is being added to the S&P 600 index.
2019-05-21 19:18:00| Fool.com Headlines
This is a case study of when a successful phase 3 trial isn't successful enough.
2019-05-19 20:00:00| Fool.com Headlines
Two rising biotech stocks. One clear long-term winner.
2019-05-19 15:00:00| Fool.com Headlines
These two biotechs could have a tortoise-and-hare kind of race going on.